| A mouse model for small round cell tumors induced by the Ewing sarcoma oncogene EWS/FLI1 T Javaheri, B Sax, H Nivarthi, E Tomazou, M Mikula, J Pencik, Z Kazemi, ... Cancer Research 74 (19_Supplement), 61-61, 2014 | | 2014 |
| A novel germline JAK2 mutation in familial myeloproliferative neoplasms E Rumi, AS Harutyunyan, I Casetti, D Pietra, H Nivarthi, R Moriggl, ... American journal of hematology 89 (1), 117-118, 2014 | 40 | 2014 |
| Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration S Gilbert, H Nivarthi, CN Mayhew, YH Lo, TK Noah, J Vallance, T Rülicke, ... Stem cell reports 4 (2), 209-225, 2015 | 72 | 2015 |
| ACTIVATED STAT5 DRIVES PERIPHERAL T CELL LYMPHOMAS B Maurer, H Nivarthi, M Prchal-Murphy, B Wingelhofer, D Chen, S Winkler, ... HAEMATOLOGICA 101, 567-567, 2016 | | 2016 |
| Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression N Kramer, J Schmöllerl, C Unger, H Nivarthi, A Rudisch, D Unterleuthner, ... Oncogene 36 (39), 5460-5472, 2017 | 128 | 2017 |
| Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants C Pecquet, I Chachoua, A Roy, T Balligand, G Vertenoeil, E Leroy, ... Blood, The Journal of the American Society of Hematology 133 (25), 2669-2681, 2019 | 91 | 2019 |
| Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis C Marty, C Pecquet, H Nivarthi, M El-Khoury, I Chachoua, M Tulliez, ... Blood, The Journal of the American Society of Hematology 127 (10), 1317-1324, 2016 | 290 | 2016 |
| Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer D Unterleuthner, P Neuhold, K Schwarz, L Janker, B Neuditschko, ... Angiogenesis 23, 159-177, 2020 | 219 | 2020 |
| CDK6 coordinates JAK2V617F mutant MPN via NF-κB and apoptotic networks IZ Uras, B Maurer, H Nivarthi, P Jodl, K Kollmann, M Prchal-Murphy, ... Blood, The Journal of the American Society of Hematology 133 (15), 1677-1690, 2019 | 37 | 2019 |
| CDK6 is an essential signaling node in JAK2V617F-mutant MPN B Maurer, IZ Uras, S Kollmann, P Jodl, K Kollmann, M Prchal-Murphy, ... FEBS OPEN BIO 9, 355-356, 2019 | | 2019 |
| Co-Expression of JAK2-V617F and Calr-del52 in vivo enhances myeloproliferative phenotype in mice and does not influence competitive fitness of hematopoietic stem cells A Majoros, H Nivarthi, R Jia, R Jäger, S Achyutuni, CM Schueller, ... Blood 136, 20, 2020 | 1 | 2020 |
| Co‐expression of mutated Jak2 and Calr enhances myeloproliferative phenotype in mice without loss of stem cell fitness CM Schueller, A Majoros, H Nivarthi, R Kralovics American Journal of Hematology 97 (11), E396-E399, 2022 | 1 | 2022 |
| Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth H Nivarthi, C Gordziel, M Themanns, N Kramer, M Eberl, B Rabe, ... Oncotarget 9 (73), 33865, 2018 | 4 | 2018 |
| Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis B Grabner, D Schramek, KM Mueller, HP Moll, J Svinka, T Hoffmann, ... Nature communications 6 (1), 6285, 2015 | 158 | 2015 |
| Frequent mutations in the calreticulin gene CALR in myeloproliferative neoplasms K Thorsten, H Gisslinger, AS Harutyunyan, H Nivarthi, E Rumi, ... Blood 122 (21), LBA-1, 2013 | 4 | 2013 |
| Hematopoietic expression of a chimeric murine‐human CALR oncoprotein allows the assessment of anti‐CALR antibody immunotherapies in vivo S Achyutuni, H Nivarthi, A Majoros, E Hug, C Schueller, R Jia, C Varga, ... American Journal of Hematology 96 (6), 698-707, 2021 | 9 | 2021 |
| Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor R Jia, T Balligand, V Atamanyuk, H Nivarthi, E Xu, L Kutzner, J Weinzierl, ... Blood, The Journal of the American Society of Hematology 137 (14), 1920-1931, 2021 | 8 | 2021 |
| High activation of STAT5A drives peripheral T-cell lymphoma and leukemia B Maurer, H Nivarthi, B Wingelhofer, HTT Pham, M Schlederer, T Suske, ... Haematologica 105 (2), 435, 2020 | 47 | 2020 |
| ID: 65: An activating STAT5 mutation is sufficient for Peripheral T Cell Lymphoma formation B Maurer, H Nivarthi, M Prchal-Murphy, B Wingelhofer, D Chen, S Winkler, ... Cytokine 76 (1), 77, 2015 | | 2015 |
| Ifnα Attenuates the Disease Phenotype and Extends Survival in Mouse Models of MPN H Nivarthi, A Majoros, E Hug, R Jia, S Achyutuni, R Jäger, R Holly, ... Blood 136, 53, 2020 | | 2020 |
